Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Human immunodeficiency virus-associated neurocognitive disorders: Mind the gap.

McArthur JC, Steiner J, Sacktor N, Nath A.

Ann Neurol. 2010 Jun;67(6):699-714. doi: 10.1002/ana.22053. Review.

PMID:
20517932
2.

Pilot study of minocycline in relapsing-remitting multiple sclerosis.

Zhang Y, Metz LM, Yong VW, Bell RB, Yeung M, Patry DG, Mitchell JR.

Can J Neurol Sci. 2008 May;35(2):185-91.

PMID:
18574932
3.

Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system.

Letendre S, Marquie-Beck J, Capparelli E, Best B, Clifford D, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Morgello S, Simpson D, Grant I, Ellis RJ; CHARTER Group.

Arch Neurol. 2008 Jan;65(1):65-70. doi: 10.1001/archneurol.2007.31.

4.

Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial.

Zuckerman RA, Lucchetti A, Whittington WL, Sanchez J, Coombs RW, Zuñiga R, Magaret AS, Wald A, Corey L, Celum C.

J Infect Dis. 2007 Nov 15;196(10):1500-8. Epub 2007 Oct 31.

PMID:
18008230
5.

Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial.

Gordon PH, Moore DH, Miller RG, Florence JM, Verheijde JL, Doorish C, Hilton JF, Spitalny GM, MacArthur RB, Mitsumoto H, Neville HE, Boylan K, Mozaffar T, Belsh JM, Ravits J, Bedlack RS, Graves MC, McCluskey LF, Barohn RJ, Tandan R; Western ALS Study Group.

Lancet Neurol. 2007 Dec;6(12):1045-53. Epub 2007 Nov 5.

PMID:
17980667
6.

Minocycline treatment in acute stroke: an open-label, evaluator-blinded study.

Lampl Y, Boaz M, Gilad R, Lorberboym M, Dabby R, Rapoport A, Anca-Hershkowitz M, Sadeh M.

Neurology. 2007 Oct 2;69(14):1404-10.

PMID:
17909152
7.

A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment.

Schifitto G, Zhang J, Evans SR, Sacktor N, Simpson D, Millar LL, Hung VL, Miller EN, Smith E, Ellis RJ, Valcour V, Singer E, Marra CM, Kolson D, Weihe J, Remmel R, Katzenstein D, Clifford DB; ACTG A5090 Team.

Neurology. 2007 Sep 25;69(13):1314-21. Epub 2007 Jul 25.

PMID:
17652642
8.

The International HIV Dementia Scale: a new rapid screening test for HIV dementia.

Sacktor NC, Wong M, Nakasujja N, Skolasky RL, Selnes OA, Musisi S, Robertson K, McArthur JC, Ronald A, Katabira E.

AIDS. 2005 Sep 2;19(13):1367-74.

PMID:
16103767
9.

Neuroprotective and anti-human immunodeficiency virus activity of minocycline.

Zink MC, Uhrlaub J, DeWitt J, Voelker T, Bullock B, Mankowski J, Tarwater P, Clements J, Barber S.

JAMA. 2005 Apr 27;293(16):2003-11.

PMID:
15855434
10.

Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection.

Carey CL, Woods SP, Gonzalez R, Conover E, Marcotte TD, Grant I, Heaton RK; HNRC Group.

J Clin Exp Neuropsychol. 2004 May;26(3):307-19.

PMID:
15512922
11.

Minocycline inhibits contusion-triggered mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury.

Teng YD, Choi H, Onario RC, Zhu S, Desilets FC, Lan S, Woodard EJ, Snyder EY, Eichler ME, Friedlander RM.

Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):3071-6. Epub 2004 Feb 23.

12.
13.

Interference effects of Stroop color-word test in childhood, adulthood, and aging.

COMALLI PE Jr, WAPNER S, WERNER H.

J Genet Psychol. 1962 Mar;100:47-53. No abstract available.

PMID:
13880724
14.

Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington's disease.

Wang X, Zhu S, Drozda M, Zhang W, Stavrovskaya IG, Cattaneo E, Ferrante RJ, Kristal BS, Friedlander RM.

Proc Natl Acad Sci U S A. 2003 Sep 2;100(18):10483-7. Epub 2003 Aug 20.

15.

A multi-center 1H MRS study of the AIDS dementia complex: validation and preliminary analysis.

Lee PL, Yiannoutsos CT, Ernst T, Chang L, Marra CM, Jarvik JG, Richards TL, Kwok EW, Kolson DL, Simpson D, Tang CY, Schifitto G, Ketonen LM, Meyerhoff DJ, Lenkinski RE, Gonzalez RG, Navia BA; HIV MRS Consortium.

J Magn Reson Imaging. 2003 Jun;17(6):625-33.

PMID:
12766890
16.

Minocycline markedly protects the neonatal brain against hypoxic-ischemic injury.

Arvin KL, Han BH, Du Y, Lin SZ, Paul SM, Holtzman DM.

Ann Neurol. 2002 Jul;52(1):54-61.

PMID:
12112047
17.

Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis.

Brundula V, Rewcastle NB, Metz LM, Bernard CC, Yong VW.

Brain. 2002 Jun;125(Pt 6):1297-308.

PMID:
12023318
18.

Minocycline prevents neurotoxicity induced by cerebrospinal fluid from patients with motor neurone disease.

Tikka TM, Vartiainen NE, Goldsteins G, Oja SS, Andersen PM, Marklund SL, Koistinaho J.

Brain. 2002 Apr;125(Pt 4):722-31.

PMID:
11912107
19.

Inhibition of autoimmune encephalomyelitis by a tetracycline.

Popovic N, Schubart A, Goetz BD, Zhang SC, Linington C, Duncan ID.

Ann Neurol. 2002 Feb;51(2):215-23.

PMID:
11835378
20.

Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease.

Du Y, Ma Z, Lin S, Dodel RC, Gao F, Bales KR, Triarhou LC, Chernet E, Perry KW, Nelson DL, Luecke S, Phebus LA, Bymaster FP, Paul SM.

Proc Natl Acad Sci U S A. 2001 Dec 4;98(25):14669-74. Epub 2001 Nov 27.

Supplemental Content

Support Center